OctoPlus' Executive Committee is responsible for the day-to-day management of our operations under the supervision of the Supervisory Board. The Executive Committee consists of Simon Sturge (CEO), Susan Swarte (CFO) and Gerben Moolhuizen (CBO).

Simon Sturge - Chief Executive Officer
Simon Sturge has over 29 years of experience in the pharmaceutical and biotech industry. He has founded and led several life sciences companies and executed a number of major business development deals. He has been on the Executive Board of several companies including Celltech, RiboTargets and Vernalis. He was CEO of Vernalis for 5 years until early 2008.

Susan Swarte - Chief Financial Officer
Susan Swarte has over 16 years of experience in financial and strategic management. She worked at Unilever and Numico (now Danone), two large, international and publicly listed companies, where she was responsible for financial, logistic and reporting aspects. At Numico she professionalised the finance function in China and most recently she was responsible for all financial aspects of the export business of Danone Baby Nutrition as Finance Director, Global Export.

Gerben Moolhuizen – Chief Business Officer
Mr. Moolhuizen received a Master’s Degree in Medical Biology from Utrecht University in 1991, studied at Tohoku University, Sendai, Japan and received an MBA from the Erasmus University of Rotterdam School of Management. He then joined Pharming Group N.V. where he held positions in Business Development, eventually becoming Director, Business Development. In 1999, Mr. Moolhuizen joined ASD B.V. (currently Primagen B.V.) as Vice-President, Business Development. He joined OctoPlus in 2001, as Senior Manager, Business Development. He became Chief Business Officer in January 2006.